These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 156065)

  • 21. Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.
    Hartmann HR; Bollag W
    Med Oncol Tumor Pharmacother; 1986; 3(2):111-8. PubMed ID: 2943952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
    Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive formation of antineoplastic 5-fluorouracil nucleosides from 5-fluorouracil by Ehrlich ascites tumor extracts in the presence of ribose 1-phosphate/uridine or deoxyribose 1-phosphate/deoxyuridine.
    Tamemasa O; Tezuka M
    J Pharmacobiodyn; 1982 Sep; 5(9):720-6. PubMed ID: 7153845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.
    Abe Y; Fukuda H; Ishiwata K; Yoshioka S; Yamada K; Endo S; Kubota K; Sato T; Matsuzawa T; Takahashi T; Ido T
    Eur J Nucl Med; 1983; 8(6):258-61. PubMed ID: 6223818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of responsiveness to 5-fluorouridine in transplantable murine leukemias.
    Kessel D; Bruns R; Hall TC
    Mol Pharmacol; 1971 Mar; 7(2):117-21. PubMed ID: 4256648
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
    Eda H; Fujimoto K; Watanabe S; Ishikawa T; Ohiwa T; Tatsuno K; Tanaka Y; Ishitsuka H
    Jpn J Cancer Res; 1993 Mar; 84(3):341-7. PubMed ID: 8486533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoropyrimidine treatment of ocular cicatricial disease.
    Heath TD; Lopez NG; Lewis GP; Stern WH
    Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):940-5. PubMed ID: 2940202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB; Klubes P
    Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and properties of 5-fluorouracil oligonucleotides.
    Koga M; Yasusa T; Yamamoto M; Haba S; Suzuki T; Saeki T; Ozaki S
    Nucleic Acids Symp Ser; 1995; (34):27-8. PubMed ID: 8841535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport and intracellular metabolism of fluorinated pyrimidines in cultured cell lines.
    Uchida M; Ho DH; Kamiya K; Yoshimura T; Sasaki K; Tsutani H; Nakamura T
    Adv Exp Med Biol; 1989; 253B():321-6. PubMed ID: 2532860
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
    In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Fluorouracil derivatives. III. A simple method to prepare 5-fluoro-2'-deoxyuridine derivatives.
    Ozaki S; Watanabe Y; Hoshiko T; Ii S; Kagawa T
    Nucleic Acids Symp Ser; 1983; (12):9-12. PubMed ID: 6229716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of the murine lymphoma L5178Y cell line highly resistant to 5-fluorouracil.
    Kanzawa F; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1980 Aug; 3(8):390-4. PubMed ID: 6451684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
    Shirasaka T; Shimamoto Y; Fukushima M
    Cancer Res; 1993 Sep; 53(17):4004-9. PubMed ID: 7689420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.